4D Molecular Therapeutics Inc Cash Flow Quality Index
4D Molecular Therapeutics Inc cash flow quality index. 4D Molecular Therapeutics Inc (FDMT) has a Cash Flow Quality Index of 1.47x as of December 2025. Operating cash flow of $28.55 Million exceeds net income of $19.40 Million, indicating high earnings quality where cash backs reported profits. See 4D Molecular Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
4D Molecular Therapeutics Inc Cash Flow Quality Index by Year (None–None)
4D Molecular Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for 4D Molecular Therapeutics Inc. For the full cash flow conversion analysis, see FDMT cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|